3.505USD-7.76%Mkt Cap: 1.08B USDP/E: —Last update: 2026-06-01
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.08B USD
Enterprise Value1.47B USD
Revenue (TTM)360.78M USD
Gross Profit261.01M USD
Net Income (TTM)5.86M USD
Revenue/Share1.309 USD
Last Price3.505 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees591
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS56400P7069
Valuation
P/E (Trailing)—
P/E (Forward)19.58
PEG4.39
EV/EBITDA41.48
EV/Revenue4.06
P/S3.23
P/B-19.64
EPS (TTM)-0.07
EPS (Forward)0.19
52W Range
2.23030% of range6.510
52W High6.510 USD
52W Low2.230 USD
Profitability
Gross Margin74.79%
Oper. Margin-3.31%
EBITDA Margin9.79%
Profit Margin1.68%
ROE-11.49%
ROA0.74%
Growth
Revenue Growth15.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.25M USD
CapEx (TTM)4.57M USD
FCF Margin13.03%
FCF Yield4.34%
Net Debt300.29M USD
Net Debt/EBITDA8.50
Balance Sheet
Debt/Equity-7.20
Current Ratio1.87
Quick Ratio1.43
Book Value/Sh-0.1920 USD
Cash/Share0.4330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 3, 2017
Splits
Last Split1:5
Split DateMar 3, 2017
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)7.469 USD
Target Range4.750 USD – 10.00 USD
# Analysts8
Ownership
Shares Out.308.95M
Float303.07M
Insiders1.55%
Institutions59.28%
Short Interest
Short Ratio4.7d
Short % Float9.65%
Short % Out.9.51%
Shares Short29.39M
Short (prev mo.)29.58M
Technical
SMA 502.847 (+23.1%)
SMA 2004.569 (-23.3%)
Beta1.04
S&P 52W Chg27.94%
Avg Vol (30d)6.17M
Avg Vol (10d)4.37M
Technical Indicators
RSI (14)71.7
MACD0.1826
MACD Signal0.1306
MACD Hist.+0.0520
BB Upper3.867 USD
BB Middle3.287 USD
BB Lower2.706 USD
BB Width35.32%
ATR (14)0.2276 USD
Vol Ratio (20d)2.29x